The Mass General Cancer Center strives to be a leading provider of continuing medical education to oncology professionals. Our CME offerings focus on cutting edge technologies, treatments and advancements in cancer research and care.
Thursdays from October–May
Simches Research Center • Boston, MA
April 21 and 28 and May 5, 12, and 19, 2021
Please join us for a five-part virtual series presented Wednesdays from 8:00-9:00 AM ET, hosted on an event platform that includes a dedicated “exhibit hall.” Each session includes two expert presentations followed by a Q&A with the presenters and a moderator.
The goal of the inaugural MAP series is to educate health care providers and team members, including industry partners, about the basics of genomics, understanding genomic reports including variants of unknown significance, and therapeutic application. Ultimately, we seek to accelerate the clinical development and clinical application of precision diagnostics and therapies for patients with cancer and to improve the outcomes for patients who are battling this difficult-to-treat disease.
- Identify the therapeutic strategies to target actionable oncogenic drivers in non-small cell lung cancer.
- Appraise the various alterations in the PI3K and MAPK pathway and potential therapeutic strategies.
- Review the role of tumor mutation burden and other tissue-agnostic biomarkers in mediating response to immunotherapy.
- Examine the components of antibody drug-conjugates and therapeutic role in solid tumors.
For more information, and to register, click here.